N-cyclopentyl-5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-hexyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-pentyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-propyl-1,3,4-oxadiazol-2-amine

C83H88F12N16O4 — CID 157228104

IUPACN-cyclopentyl-5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-hexyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-pentyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-propyl-1,3,4-oxadiazol-2-amine
SMILESCCCCCCNc1nnc(-c2cc(C)c3cc(C4CC4)cc(C(F)(F)F)c3n2)o1.CCCCCNc1nnc(-c2cc(C)c3cc(C4CC4)cc(C(F)(F)F)c3n2)o1.CCCNc1nnc(-c2cc(C)c3cc(C4CC4)cc(C(F)(F)F)c3n2)o1.Cc1cc(-c2nnc(NC3CCCC3)o2)nc2c(C(F)(F)F)cc(C3CC3)cc12
InChIInChI=1S/C22H25F3N4O.C21H21F3N4O.C21H23F3N4O.C19H19F3N4O/c1-3-4-5-6-9-26-21-29-28-20(30-21)18-10-13(2)16-11-15(14-7-8-14)12-17(19(16)27-18)22(23,24)25;1-11-8-17(19-27-28-20(29-19)25-14-4-2-3-5-14)26-18-15(11)9-13(12-6-7-12)10-16(18)21(22,23)24;1-3-4-5-8-25-20-28-27-19(29-20)17-9-12(2)15-10-14(13-6-7-13)11-16(18(15)26-17)21(22,23)24;1-3-6-23-18-26-25-17(27-18)15-7-10(2)13-8-12(11-4-5-11)9-14(16(13)24-15)19(20,21)22/h10-12,14H,3-9H2,1-2H3,(H,26,29);8-10,12,14H,2-7H2,1H3,(H,25,28);9-11,13H,3-8H2,1-2H3,(H,25,28);7-9,11H,3-6H2,1-2H3,(H,23,26)
InChIKeyATUAMMPMTOHVPQ-UHFFFAOYSA-N
MW1601.70 g/mol
LogP23.73
Rot. Bonds24

About N-cyclopentyl-5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-hexyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-pentyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-propyl-1,3,4-oxadiazol-2-amine

N-cyclopentyl-5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-hexyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-pentyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-propyl-1,3,4-oxadiazol-2-amine (PubChem CID 157228104) has the molecular formula C83H88F12N16O4 and a molecular weight of 1601.70 g/mol. Its IUPAC name is N-cyclopentyl-5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-hexyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-pentyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-propyl-1,3,4-oxadiazol-2-amine.

Molecular Properties

Compound NameN-cyclopentyl-5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-hexyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-pentyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-propyl-1,3,4-oxadiazol-2-amine
PubChem CID157228104
Molecular FormulaC83H88F12N16O4
Molecular Weight1601.70 g/mol
Exact Mass1600.70
IUPAC NameN-cyclopentyl-5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-hexyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-pentyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-propyl-1,3,4-oxadiazol-2-amine
SMILESCCCCCCNc1nnc(-c2cc(C)c3cc(C4CC4)cc(C(F)(F)F)c3n2)o1.CCCCCNc1nnc(-c2cc(C)c3cc(C4CC4)cc(C(F)(F)F)c3n2)o1.CCCNc1nnc(-c2cc(C)c3cc(C4CC4)cc(C(F)(F)F)c3n2)o1.Cc1cc(-c2nnc(NC3CCCC3)o2)nc2c(C(F)(F)F)cc(C3CC3)cc12
InChIInChI=1S/C22H25F3N4O.C21H21F3N4O.C21H23F3N4O.C19H19F3N4O/c1-3-4-5-6-9-26-21-29-28-20(30-21)18-10-13(2)16-11-15(14-7-8-14)12-17(19(16)27-18)22(23,24)25;1-11-8-17(19-27-28-20(29-19)25-14-4-2-3-5-14)26-18-15(11)9-13(12-6-7-12)10-16(18)21(22,23)24;1-3-4-5-8-25-20-28-27-19(29-20)17-9-12(2)15-10-14(13-6-7-13)11-16(18(15)26-17)21(22,23)24;1-3-6-23-18-26-25-17(27-18)15-7-10(2)13-8-12(11-4-5-11)9-14(16(13)24-15)19(20,21)22/h10-12,14H,3-9H2,1-2H3,(H,26,29);8-10,12,14H,2-7H2,1H3,(H,25,28);9-11,13H,3-8H2,1-2H3,(H,25,28);7-9,11H,3-6H2,1-2H3,(H,23,26)
InChIKeyATUAMMPMTOHVPQ-UHFFFAOYSA-N
XLogP23.73
TPSA255.36 Ų
H-Bond Donors4
H-Bond Acceptors20
Rotatable Bonds24
Heavy Atoms115
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001601.70
LogP ≤ 523.73
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-cyclopentyl-5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-hexyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-pentyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-propyl-1,3,4-oxadiazol-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-cyclopentyl-5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-hexyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-pentyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-propyl-1,3,4-oxadiazol-2-amine?
The IUPAC name of N-cyclopentyl-5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-hexyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-pentyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-propyl-1,3,4-oxadiazol-2-amine (CID 157228104) is N-cyclopentyl-5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-hexyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-pentyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-propyl-1,3,4-oxadiazol-2-amine.
What is the SMILES notation for N-cyclopentyl-5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-hexyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-pentyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-propyl-1,3,4-oxadiazol-2-amine?
The canonical SMILES for N-cyclopentyl-5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-hexyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-pentyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-propyl-1,3,4-oxadiazol-2-amine is CCCCCCNc1nnc(-c2cc(C)c3cc(C4CC4)cc(C(F)(F)F)c3n2)o1.CCCCCNc1nnc(-c2cc(C)c3cc(C4CC4)cc(C(F)(F)F)c3n2)o1.CCCNc1nnc(-c2cc(C)c3cc(C4CC4)cc(C(F)(F)F)c3n2)o1.Cc1cc(-c2nnc(NC3CCCC3)o2)nc2c(C(F)(F)F)cc(C3CC3)cc12.
What is the InChIKey of N-cyclopentyl-5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-hexyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-pentyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-propyl-1,3,4-oxadiazol-2-amine?
The InChIKey is ATUAMMPMTOHVPQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H25F3N4O.C21H21F3N4O.C21H23F3N4O.C19H19F3N4O/c1-3-4-5-6-9-26-21-29-28-20(30-21)18-10-13(2)16-11-15(14-7-8-14)12-17(19(16)27-18)22(23,24)25;1-11-8-17(19-27-28-20(29-19)25-14-4-2-3-5-14)26-18-15(11)9-13(12-6-7-12)10-16(18)21(22,23)24;1-3-4-5-8-25-20-28-27-19(29-20)17-9-12(2)15-10-14(13-6-7-13)11-16(18(15)26-17)21(22,23)24;1-3-6-23-18-26-25-17(27-18)15-7-10(2)13-8-12(11-4-5-11)9-14(16(13)24-15)19(20,21)22/h10-12,14H,3-9H2,1-2H3,(H,26,29);8-10,12,14H,2-7H2,1H3,(H,25,28);9-11,13H,3-8H2,1-2H3,(H,25,28);7-9,11H,3-6H2,1-2H3,(H,23,26).
What are the key properties of N-cyclopentyl-5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-hexyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-pentyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-propyl-1,3,4-oxadiazol-2-amine?
N-cyclopentyl-5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-hexyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-pentyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-propyl-1,3,4-oxadiazol-2-amine has a molecular weight of 1601.70 g/mol, XLogP of 23.73, 24 rotatable bonds, 4 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N-cyclopentyl-5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-hexyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-pentyl-1,3,4-oxadiazol-2-amine;5-[6-cyclopropyl-4-methyl-8-(trifluoromethyl)quinolin-2-yl]-N-propyl-1,3,4-oxadiazol-2-amine is sourced from PubChem (CID 157228104), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).